Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follicular Lymphoma (FL) in the First-Line Setting:

@inproceedings{Davies2012PharmacokineticsS,
  title={Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follicular Lymphoma (FL) in the First-Line Setting:},
  author={Andrew Meredith Davies and Francesco Merli and Biljana Mihaljevik and Noppadol Siritanaratkul and Philippe Solal-C{\'e}ligny and Axel Boehnke and Claude Berge and Christine McIntyre and Martin Barrett and David Macdonald},
  year={2012}
}